Stock comparison
AxoGen
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
AXGN
AxoGen
Market cap
$2.17B
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | AXGN | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 19F | 69B | MTD |
| Benjamin Graham | 54D | 65B | MTD |
| Philip Fisher | 40D | 63C | MTD |
| Peter Lynch | 27F | 66B | MTD |
| Joel Greenblatt | 0F | 68B | MTD |
| Charlie Munger | 26F | 74B | MTD |
| Terry Smith | 27F | 70B | MTD |
Side-by-side metrics
| Metric | AXGN | MTD |
|---|---|---|
| Market cap | $2.17B | $22.29B |
| P/E (TTM) | - | 25.3x |
| EV/EBIT | - | 21.6x |
| ROIC (TTM) | -3.4% | 36.09% |
| Gross margin | 75.01% | 57.79% |
| Net margin | -13.21% | 21.4% |
| Revenue CAGR 5y | 15.32% | 2.01% |
| EPS CAGR 5y | - | 6.12% |
| Debt / Equity | 0.1x | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
AXGN leads on
- P/E (TTM)-vs 25.3x+137%
- EV/EBIT-vs 21.6x+108%
- Revenue CAGR 5y15.32%vs 2.01%+87%
- Gross margin75.01%vs 57.79%+23%
MTD leads on
- Net margin21.4%vs -13.21%+162%
- ROIC (TTM)36.09%vs -3.4%+109%
- Debt / Equity-vs 0.1x+100%
- Market cap$22.29Bvs $2.17B+90%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.